| Name | Title | Contact Details |
|---|
Every day, Graybug Vision works relentlessly to make healthy vision more accessible and more manageable for patients with chronic vision-threatening eye diseases. We are a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of chronic diseases of the retina and optic nerve. Our novel technologies are designed to release drugs in ocular tissue at a controlled rate for up to 12 months in order to improve patient compliance, reduce healthcare burdens and, ultimately, deliver better clinical outcomes.
Wraser Pharmaceuticals is a Ridgeland, MS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Embecta will be the name of the independent, publicly-traded company that will hold BD`s Diabetes Care business
Pharma Test-Americas is a Markham, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Standard Process Inc is a Palmyra, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.